IP Library Granted Patent US 8,679,189
Granted Patent B1
US 8,679,189 · App. 13/767,055 · Granted Mar 25, 2014

Bone growth enhancing implant

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,679,189
App. No.
13/767,055
Granted
Mar 25, 2014
Kind
B1
Abstract

An implant device having a non-conductive base structure with at least two exposed or exterior surfaces wherein at least one of the exposed or exterior surfaces has attained electrical conductivity on at least portions of the surface by an energy exposure wherein portions of the exposed or exterior surfaces are transformed by the energy exposure to attain the electrical conductivity.

Claims (25)

1. A bone growth enhancing implant device comprises:

a non-conductive base structure with at least two exposed or exterior surfaces wherein at least one of the exposed or exterior surfaces has attained electrical conductivity by creating or forming conductive paths or patterns of conductive networks on at least portions of the surface by an energy exposure wherein portions of the exposed or exterior surfaces are transformed by the energy exposure to attain the electrical conductivity at the conductive paths or patterns leaving the rest of the base structure not in the paths or patterns unaltered, wherein the base structure is preferably made of an organic carbon or hydrocarbon base material composition of a synthetically produced polymer of a plastic material.

2. The bone growth enhancing implant device of claim 1 wherein the non-conductive base structure received the energy exposure in the form of a spectrum of wavelengths in the visible or non-visible range sufficient to create a material composition change to the base structure at the exposed or exterior surfaces.

3. The bone growth enhancing implant device of claim 1 wherein the material composition changes from an organic non-conductive polymer to an amorphous carbon at the conductive path or pattern.

4. The bone growth enhancing implant device of claim 3 wherein a material composition change results in a formation of conductive carbon paths or patterns formed as channels of conductive carbon residue extending at the surface to a depth of 1 to 2 or more microns occurring at the conductive paths or patterns of conductive networks.

5. The bone growth enhancing implant device of claim 4 wherein the conductive paths are formed in interconnected networks to allow electrical current to flow along the surface.

6. The bone growth enhancing implant device of claim 5 wherein the paths are small, from a few microns up to several hundred microns wide and formed in discrete channels at the surface extending to a depth of a few microns.

7. The bone growth enhancing implant device of claim 6 wherein these conductive paths react electrically to the low voltages carried by cells to enhance new bone formation at the surface of the implant device.

8. The bone growth enhancing implant device of claim 7 wherein the paths have a resistivity under 500 ohms.

9. The bone growth enhancing implant device of claim 3 wherein the material composition change results in a formation of conductive carbon paths or patterns formed as channels of conductive carbon residue extending at the surface to a depth of 1 to 2 or more microns, and that resistivity is variable, variegated, and follows domains that offer electrodynamic topology.

10. The bone growth enhancing implant device of claim 1 wherein the body structure is made of an implantable grade synthetic plastic, which is a thermoplastic or thermoset material.

11. The bone growth enhancing implant device of claim 10 wherein the plastic material can be any implantable grade material such as PEEK (polyether ether ketone), PEKK (polyether ketone ketone), polyethylene, ultra high molecular weight polyethylene, polyphenylsulfone, polysulfone, polythermide, acetal copolymer, polyester woven or solid or implantable grade lennite UHME-PE or other suitable implant material.

12. The bone growth enhancing implant device of claim 1 wherein the implant device includes anchoring holes to secure the device to the skeletal structure with fasteners or alternatively can simply be held in place by and between adjacent skeletal structures.

13. The bone growth enhancing implant device of claim 1 wherein the implant device is built by additive fabrication through a process offering reproducible and reconcilable formation to the istropic domains inherent to the marine mammal cancellous bone wherein, the internal structure is modeled for strength, neutralized for strain, and open to surface modification of its entire network of trabecular permutations.

14. The bone growth enhancing implant device of claim 1 wherein the energy used to create the conductive paths or patterns comes from a laser source.

15. The bone growth enhancing implant device of claim 14 wherein lasers provide such an energy source which occurs in a reduced oxygen environment so as to create discrete conductive paths in the absence of surface scorching, insuring the base structure is only made conductive at the paths or patterns leaving the rest of the base structure unaltered.

16. The bone growth enhancing implant device of claim 1 wherein the energy used to create the conductive paths or patterns comes from an acoustic source such as a focused acoustic lens, wherein the emitted wavelength can impinge the surface to create a chemical transformation to achieve conductive carbon residue paths or patterns.

17. The bone growth enhancing implant device of claim 1 wherein the enhanced implant device further comprises a 3-dimensional surface texture of voids at exposed surfaces that provide cell attachment locations in addition to the conductive paths wherein the combination accelerates new bone formation.

18. A bone growth enhancing implant device comprises:

a non-conductive base structure with at least two exposed or exterior surfaces wherein at least one of the exposed or exterior surfaces has attained electrical conductivity by creating or forming conductive paths or patterns of conductive networks on at least portions of the surface by an energy exposure wherein portions of the exposed or exterior surfaces are transformed by the energy exposure to attain the electrical conductivity at the conductive paths or patterns leaving the rest of the base structure not in the paths or patterns unaltered, wherein the implant device is a naturally occurring material such as an allograft bone tissue used for implantation in a mammal.

19. The bone growth enhancing implant device of claim 18 wherein the conductive paths have a resistivity under 500 ohms.

20. The bone growth enhancing implant device is made by a method having the steps of:

providing a non-conductive base structure of an implant having exterior or exposed surfaces; and

exposing at least one or more of the surfaces to an energy source to transform those surfaces of the base structure into electrically conductive paths or networks and leaving the rest of the base structure not in the paths or networks remain unaltered.

21. The method of claim 20 further includes the step of using a laser beam in an oxygen reduced environment to create amorphous carbon channels to form the conductive paths or networks.

Assignments (17)
RELEASE OF SECURITY INTEREST Recorded Jun 3, 2024
From: ANTARES CAPITAL LP, AS ADMINISTRATIVE AGENT
To: SPINAL ELEMENTS, INC. (F.K.A. AMENDIA, INC.)
Reel/Frame 067605/0626 →
RELEASE OF SECURITY INTEREST Recorded Jun 3, 2024
From: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
To: SPINAL ELEMENTS, INC. (F.K.A. AMENDIA, INC.)
Reel/Frame 067605/0676 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2021
From: GANEY, TIMOTHY
To: BONE PHARM, LLC
Reel/Frame 055780/0116 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2020
From: VIVEX BIOMEDICAL, INC.
To: GANEY, TIMOTHY
Reel/Frame 053772/0339 →
SECURITY INTEREST Recorded Mar 2, 2020
From: SPINAL ELEMENTS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 051983/0474 →
SECURITY INTEREST Recorded Feb 19, 2020
From: SPINAL ELEMENTS, INC.
To: ANTARES CAPITAL LP, AS AGENT
Reel/Frame 051856/0135 →
RELEASE OF SECURITY INTEREST Recorded Dec 12, 2019
From: HERITAGE BANK OF COMMERCE
To: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
Reel/Frame 051282/0653 →
RELEASE OF SECURITY INTEREST Recorded Mar 28, 2017
From: SILICON VALLEY BANK
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 042103/0686 →
SECURITY INTEREST Recorded Feb 22, 2017
From: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC.; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 041782/0452 →
RELEASE OF SECURITY INTEREST Recorded Apr 29, 2016
From: SILICON VALLEY BANK, AS ADMINISTRATIVE AGENT
To: AMENDIA, INC.; OMNI ACQUISITION INC.
Reel/Frame 038578/0828 →
SECURITY INTEREST Recorded Jan 5, 2016
From: VIVEX BIOMEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 037413/0089 →
RELEASE OF SECURITY INTEREST Recorded Sep 18, 2014
From: JPMORGAN CHASE BANK, N.A.
To: AMENDIA, INC.
Reel/Frame 033771/0759 →
PATENT SECURITY AGREEMENT Recorded Sep 9, 2014
From: AMENDIA, INC.; OMNI ACQUISITION, INC.
To: SILICON VALLEY BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 033696/0940 →
SECURITY INTEREST Recorded Jun 10, 2014
From: AMENDIA, INC.
To: JP MORGAN CHASE BANK NA
Reel/Frame 033120/0286 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2014
From: AMENDIA, INC.
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 032514/0991 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 24, 2013
From: LIVINGSTON, FRANK EDWARD
To: THE AEROSPACE CORPORATION
Reel/Frame 031845/0930 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2013
From: GANEY, TIMOTHY
To: AMENDIA INC.
Reel/Frame 029816/0990 →